# REtinal Markers In Neuroinflammatory Diseases ("REMIND")

> **NCT06369766** · — · RECRUITING · sponsor: **University Hospital, Basel, Switzerland** · enrollment: 500 (estimated)

## Conditions studied

- Multiple Sclerosis
- Neuroinflammatory Diseases

## Interventions

- **DIAGNOSTIC_TEST:** Optical coherence tomography (OCT)
- **DIAGNOSTIC_TEST:** Static retinal vessel analyzer
- **DIAGNOSTIC_TEST:** Dynamic retinal vessel analyzer
- **DIAGNOSTIC_TEST:** Laser speckle flowgraphy system
- **OTHER:** Questionnaire

## Key facts

- **NCT ID:** NCT06369766
- **Lead sponsor:** University Hospital, Basel, Switzerland
- **Sponsor class:** OTHER
- **Phase:** —
- **Study type:** OBSERVATIONAL
- **Status:** RECRUITING
- **Start date:** 2024-01-31
- **Primary completion:** 2028-12
- **Final completion:** 2029-02
- **Target enrollment:** 500 (ESTIMATED)
- **Last updated:** 2025-05-23

## Collaborators

- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT06369766

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT06369766, "REtinal Markers In Neuroinflammatory Diseases ("REMIND")". Retrieved via AI Analytics 2026-06-25 from https://api.ai-analytics.org/clinical/NCT06369766. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*